131 related articles for article (PubMed ID: 10660735)
21. Concurrent chemoradiotherapy with pirarubicin and 5-fluorouracil for resectable oral and maxillary carcinoma.
Iguchi H; Kusuki M; Nakamura A; Nishiura H; Kanazawa A; Takayama M; Sunami K; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):55-61. PubMed ID: 15513513
[TBL] [Abstract][Full Text] [Related]
22. Preoperative chemoradiotherapy in the management of oral cancer: a review.
Klug C; Berzaczy D; Voracek M; Millesi W
J Craniomaxillofac Surg; 2008 Mar; 36(2):75-88. PubMed ID: 18222699
[TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy with nedaplatin (CDGP) and 5-FU for oral cancer].
Maruoka Y; Ando T; Hoshino M; Ogiuchi Y; Nishihara N; Okamoto T; Fukada K; Kuwazawa T; Ogiuchi H
Gan To Kagaku Ryoho; 2002 Mar; 29(3):421-5. PubMed ID: 11915732
[TBL] [Abstract][Full Text] [Related]
24. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
25. [Neoadjuvant radiochemotherapy for squamous cell carcinoma of the oral cavity].
Bootz F
HNO; 2008 Feb; 56(2):183-4. PubMed ID: 18231725
[No Abstract] [Full Text] [Related]
26. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
27. [Non-randomized clinical study comparing chemotherapy plus radiotherapy with radiotherapy alone in neoadjuvant therapy for oral cancer].
Kayahara H; Okuda M; Terakado N; Shintani S; Hamakawa H
Gan To Kagaku Ryoho; 2002 Jun; 29(6):911-6. PubMed ID: 12090043
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
29. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
30. [Cell kinetics of oral cancer during gamma teletherapy in combination with the administration of metronidazole].
Karakulov RK; Poliakov PIu; Dar'ialova SL; Kiseleva ES; Pelevina II
Med Radiol (Mosk); 1983 May; 28(5):39-44. PubMed ID: 6855494
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant chemotherapy in the treatment of intra-oral squamous cell carcinoma.
Chander S; Ghosh D
Indian J Cancer; 1987 Jun; 24(2):67-72. PubMed ID: 2447013
[No Abstract] [Full Text] [Related]
32. [Combined preoperative therapy for oral cancer with nedaplatin and radiation].
Adachi M; Shibata A; Hayashi M; Satoh D; Miyasaka T; Yanai C; Kawatsu N; Yagishita H; Ogino Y; Yamashita N; Suzuki M
Gan To Kagaku Ryoho; 2002 Mar; 29(3):465-7. PubMed ID: 11915741
[TBL] [Abstract][Full Text] [Related]
33. Radiation following surgery for oral cancer: impact on local control.
Magge KT; Myers EN; Johnson JT
Laryngoscope; 2003 Jun; 113(6):933-5. PubMed ID: 12782799
[TBL] [Abstract][Full Text] [Related]
34. [Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin (CDGP) and 5-FU with concurrent radiotherapy for advanced oral cancer].
Aoki K; Tatebayashi S; Imai Y; Yamakawa N; Yagyuu T; Kajihara A; Nakagawa H; Kirita T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1777-81. PubMed ID: 18030010
[TBL] [Abstract][Full Text] [Related]
35. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
36. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
37. Current radiation therapy management issues in oral cavity cancer.
Ballonoff A; Chen C; Raben D
Otolaryngol Clin North Am; 2006 Apr; 39(2):365-80. PubMed ID: 16580917
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
[TBL] [Abstract][Full Text] [Related]
40. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
